Ilaprazole, a new proton pump inhibitor, is primarily metabolized to ilaprazole sulfone by CYP3A4 and 3A5

Author： Seo Kyung-Ah   Lee So-Jeong   Kim Kwon-Bok   Bae Soo Kyung   Liu Kwang-Hyeon   Kim Dong-Hyun   Shin Jae-Gook  

Publisher： Informa Healthcare

ISSN： 1366-5928

Source： Xenobiotica, Vol.42, Iss.3, 2012-03, pp. : 278-284

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparative analysis of substrate and inhibitor interactions with CYP3A4 and CYP3A5

By Soars M. G.   Grime K.   Riley R. J.  

Xenobiotica, Vol. 36, Iss. 4, 2006-04 ,pp. : 287-299

Informa Healthcare

Access to resources Recommend Favorite

Different effects of proton pump inhibitors and famotidine on the clopidogrel metabolic activation by recombinant CYP2B6, CYP2C19 and CYP3A4

By Ohbuchi Masato   Noguchi Kiyoshi   Kawamura Akio   Usui Takashi  

Xenobiotica, Vol. 42, Iss. 7, 2012-07 ,pp. : 633-640

Informa Healthcare

Access to resources Recommend Favorite

In vitro metabolism of piperaquine is primarily mediated by CYP3A4

By Lee Tina Ming-Na   Huang Liusheng   Johnson Marla K.   Lizak Patricia   Kroetz Deanna   Aweeka Francesca   Parikh Sunil  

Xenobiotica, Vol. 42, Iss. 11, 2012-11 ,pp. : 1088-1095

Informa Healthcare

Access to resources Recommend Favorite

Homology modelling of CYP3A4 from the CYP2C5 crystallographic template: analysis of typical CYP3A4 substrate interactions

By Lewis D. F. V.   Lake B. G.   Dickins M.   Goldfarb P. S.  

Xenobiotica, Vol. 34, Iss. 6, 2004-06 ,pp. : 549-569

Informa Healthcare

Access to resources Recommend Favorite

Enzymatic characteristics of CYP3A5 and CYP3A4: A comparison of in vitro kinetic and drug–drug interaction patterns

By Emoto C.   Iwasaki K.  

Xenobiotica, Vol. 36, Iss. 2-3, 2006-02 ,pp. : 219-233

Informa Healthcare

Access to resources Recommend Favorite